Results 111 to 120 of about 5,456,142 (288)

Dynamic changes in the mouse hepatic lipidome following warm ischemia reperfusion injury

Scientific Reports
Liver failure secondary to metabolic dysfunction-associated steatotic liver disease (MASLD) has become the most common cause for liver transplantation in many parts of the world.
Kim H. H. Liss, Muhammad Mousa, Shria Bucha, Andrew Lutkewitte, Jeremy Allegood, L. Ashley Cowart, Brian N. Finck   +6 more
doaj   +1 more source

Special Issue “Liver Fibrosis: Mechanisms, Targets, Assessment and Treatment”

Livers
Liver fibrosis is a significant challenge in hepatology, as it represents the common pathway of chronic liver injury due to various causes such as viral hepatitis, metabolic dysfunction-associated steatotic liver disease (MASLD), intoxication, alcohol ...
Ralf Weiskirchen, Tilman Sauerbruch
doaj   +1 more source

Beyond the Heart: Hepatic Extracellular Volume Assessment in Patients With Cardiovascular Disease

Journal of Magnetic Resonance Imaging, EarlyView.
Kenichiro Suwa, Yuichiro Maekawa
wiley   +1 more source

Chronic, Environmentally Relevant PM2.5 Exposure Exacerbates Metabolic Dysfunction‐Associated Steatotic Liver Disease and Early‐Stage Renal Dysfunction in a Rodent Model

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT While epidemiological studies link fine particulate matter (PM2.5) exposure to metabolic dysfunction‐associated steatotic liver disease (MASLD) and renal dysfunction, a translational gap exists, as most animal models utilize acute, high‐dose exposures that poorly reflect chronic, moderate‐level human scenarios.
Yi‐Siao Chen, Hugo You‐Hsien Lin, Chien‐Tzu Lin, Si‐Hua Huang, Ming‐Lun Yeh, Ming‐Lung Yu, Jin‐Ching Lee, Yao‐Chi Chung, Wei‐Ming Li, Ching‐Chia Li, Shiu‐Feng Huang, Chia‐Hung Yen   +11 more
wiley   +1 more source

Impact of steatotic liver disease categories on atrial fibrillation in type 2 diabetes: a nationwide study

Scientific Reports
This study aims to investigate the incidence of new-onset atrial fibrillation (AF) in individuals with type 2 diabetes mellitus (T2DM) across different categories of steatotic liver disease (SLD). Using a health examination database between 2009 and 2012,
So Hyun Cho, Gyuri Kim, Kyu-na Lee, Rosa Oh, Ji Yoon Kim, Myunghwa Jang, You-Bin Lee, Sang-Man Jin, Kyu Yeon Hur, Kyungdo Han, Jae Hyeon Kim   +10 more
doaj   +1 more source

Impact of Cardiometabolic Risk Factors and Steatotic Liver Disease on Liver‐Related Outcomes in Patients With Chronic Hepatitis C After Curative Antiviral Therapy

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Patients with chronic hepatitis C (CHC) frequently present with steatotic liver disease (SLD) and cardiometabolic risk factors (CMRFs). This study aimed to evaluate the impact of SLD and CMRFs on liver‐related outcomes (LROs) in CHC patients after HCV eradication.
Chung‐Feng Huang, Yi‐Hung Lin, Pei‐Chien Tsai, Ming‐Lun Yeh, Chih‐Wen Wang, Tyng‐Yuan Jang, Po‐Cheng Liang, Yu‐Ju Wei, Nai‐Jen Hou, Ming‐Yen Hsieh, Chao‐Kuan Huang, Tzu‐Chun Lin, Jee‐Fu Huang, Chia‐Yen Dai, Wan‐Long Chuang, Ming‐Lung Yu   +15 more
wiley   +1 more source

Exploring the therapeutic potential of mitochondrial mechanism in metabolic dysfunction associated steatotic liver disease

Egyptian Liver Journal
Background Metabolic dysfunction-associated steatotic liver disease has emerged as the most prevalent liver disease with a rapidly increasing incidence worldwide. Targeting mitochondria in this condition opens up innovative avenues for the development of
Karthika Selvam, Shalinipriya Muthulakshmi Chinnaswamy, Sathish Jawahar, Venkatesh Gunasekaran   +3 more
doaj   +1 more source

Protective Effects of Cymbopogon citratus Against Experimental Steatotic Liver Disease Through Modulation of Oxidative Stress and Inflammation in Male Rats

مجلة بحوث التربية النوعية
Background: Experimental steatotic liver disease is characterized by excessive lipid accumulation within hepatocytes, accompanied by oxidative stress, inflammatory responses, and progressive impairment of liver function.
هناء فاروق محمد المهيري
doaj   +1 more source

Impact of coronary artery disease on steatotic liver disease progression

Вступ. Стеатотична хвороба печінки, асоційована з метаболічною дисфункцією та ішемічна хвороба серця належать до захворювань із взаємообтяжуючим перебігом.
Пілат, Інна Олегівна, Скрипник, Ігор Миколайович, Skrypnyk, I. M., Pilat, I. O.   +3 more
core   +1 more source

Efficacy of CPAP Therapy on Liver Steatosis and Insulin Resistance in Fatty Liver Patients With Obstructive Sleep Apnea: A 4‐Year Follow‐Up Cohort Study

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Metabolic dysfunction‐associated steatotic liver disease (MASLD) and obstructive sleep apnea (OSA) are comorbid conditions that synergistically increase cardiovascular risk through systemic inflammation and insulin resistance. While continuous positive airway pressure (CPAP) is the standard treatment for OSA, its efficacy in improving hepatic ...
Hsiao‐Chin Shen, Yen‐Hsun Huang, Tzu‐Hao Li, Chih‐Hsun Wu, Yu‐Wei Lee, Hsiao‐Yun Yeh, Hung‐Cheng Tsai, Chien‐Wei Su, Kun‐Ta Chou, Ying‐Ying Yang, Ming‐Chih Hou   +10 more
wiley   +1 more source